Sensible biotechnologies raises $4.2mn in a pre-seed financing round to revolutionize mrna manufacturing

Sensible biotechnologies aims to build a cell-based platform for cost-efficient and scalable manufacturing of high-quality mrna. proceeds will be used to optimize and scale sensible's mrna manufacturing platform and mrna design capabilities.
DNA Ratings Summary
DNA Quant Ranking